| Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing S Sadegh, J Matschinske, DB Blumenthal, G Galindez, T Kacprowski, ... Nature communications 11 (1), 3518, 2020 | 171 | 2020 |
| Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies G Galindez, J Matschinske, TD Rose, S Sadegh, M Salgado-Albarrán, ... Nature Computational Science 1 (1), 33-41, 2021 | 111 | 2021 |
| Network medicine for disease module identification and drug repurposing with the NeDRex platform S Sadegh, J Skelton, E Anastasi, J Bernett, DB Blumenthal, G Galindez, ... Nature communications 12 (1), 6848, 2021 | 68 | 2021 |
| New insights into radioresistance in breast cancer identify a dual function of miR‐122 as a tumor suppressor and oncomiR IX Perez‐Añorve, CH Gonzalez‐De la Rosa, E Soto‐Reyes, ... Molecular oncology 13 (5), 1249-1267, 2019 | 57 | 2019 |
| Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection M Salgado-Albarrán, EI Navarro-Delgado, A Del Moral-Morales, ... NPJ systems biology and applications 7 (1), 21, 2021 | 42 | 2021 |
| The regulatory roles of non-coding RNAs in angiogenesis and neovascularization from an epigenetic perspective IA Hernández-Romero, L Guerra-Calderas, M Salgado-Albarrán, ... Frontiers in oncology 9, 1091, 2019 | 36 | 2019 |
| Analyzing Network Data in Biology and Medicine: An Interdisciplinary Textbook for Biological, Medical and Computational Scientists N Pržulj Cambridge University Press, 2019 | 21 | 2019 |
| The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancer M Salgado-Albarrán, R González-Barrios, L Guerra-Calderas, N Alcaraz, ... Oncogenesis 8 (8), 41, 2019 | 20 | 2019 |
| Caracterización de patrones de hordeínas en variedades mexicanas de cebada maltera M Salgado-Albarrán, J Herrera-Díaz, TD Dinkova TIP Revista Especializada en Ciencias Químico-Biológicas 18 (1), 43-51, 2015 | 15 | 2015 |
| CTCF-KDM4A complex correlates with histone modifications that negatively regulate CHD5 gene expression in cancer cell lines L Guerra-Calderas, R González-Barrios, CC Patiño, N Alcaraz, ... Oncotarget 9 (24), 17028, 2018 | 10 | 2018 |
| Individuating possibly repurposable drugs and drug targets for COVID-19 treatment through hypothesis-driven systems medicine using CoVex J Matschinske, M Salgado-Albarrán, S Sadegh, D Bongiovanni, ... Assay and drug development technologies 18 (8), 348-355, 2020 | 8 | 2020 |
| CTCF and its multi-partner network for chromatin regulation A Del Moral-Morales, M Salgado-Albarrán, Y Sánchez-Pérez, NK Wenke, ... Cells 12 (10), 1357, 2023 | 7 | 2023 |
| Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing. Nat Commun 11: 3518 S Sadegh, J Matschinske, DB Blumenthal, G Galindez, T Kacprowski, ... | 7 | 2020 |
| The Transcriptional Regulatory Network of Corynebacterium pseudotuberculosis D Parise, M Teixeira Dornelles Parise, AC Pinto Gomide, ... Microorganisms 9 (2), 415, 2021 | 6 | 2021 |
| CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy M Salgado-Albarrán, J Späth, R González-Barrios, J Baumbach, ... npj Systems Biology and Applications 8 (1), 5, 2022 | 5 | 2022 |
| Bioinformatics and human genomics research DA Forero CRC Press, 2022 | 2 | 2022 |
| Ariston de Carvalho Azevedo, V.; Baumbach, J. The Transcriptional Regulatory Network of Corynebacterium pseudotuberculosis. Microorganisms 2021, 9, 415 D Parise, M Teixeira Dornelles Parise, AC Pinto Gomide, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 2 | 2021 |
| Transcriptomic and Drug Discovery Analyses Reveal Natural Compounds Targeting the KDM4 Subfamily as Promising Adjuvant Treatments in Cancer A del Moral-Morales, M Salgado-Albarrán, E Ortiz-Gutiérrez, ... Frontiers in Genetics 13, 860924, 2022 | 1 | 2022 |
| Streamlining and generalizing network-based drug discovery with NeDRex and Drugst. One FM Delgado-Chaves, S Sadegh, J Skelton, A Maier, M Hartung, ... RExPO23, 2023 | | 2023 |
| Targeting infectious diseases: The CoVex example S Sadegh, J Matschinske, DB Blumenthal, G Galindez, T Kacprowski, ... RExPO22, 2022 | | 2022 |
